Boston 3T Biotechnologies Inc.
Overview
Through our patent pending cancer technologies, we address both the humanitarian as well as the economic issues relating to cancer, both solid, as well as liquid tumors. We have passed the "discovery stage", and are ready to enter the next stage of testing . Our targeted customer will likely be a large pharmaceutical company to partner with Boston 3T Biotechnology through a licensing or sales of our technology.